Didesmethylsibutramine: Difference between revisions

Revision as of 11:05, 15 February 2025

Didesmethylsibutramine

File:Didesmethylsibutramine BTS-54524.svg

Chemical structure of Didesmethylsibutramine

Didesmethylsibutramine is a chemical compound that is a metabolite of the drug sibutramine. Sibutramine is a medication that was used as an appetite suppressant for the treatment of obesity. Didesmethylsibutramine is formed in the body through the metabolic process of N-demethylation, which removes methyl groups from the parent compound.

Chemical Properties

Didesmethylsibutramine is classified as a phenethylamine and an amphetamine derivative. Its chemical structure is characterized by the presence of a phenyl ring and an amine group, which are common features in compounds that affect the central nervous system.

Pharmacology

As a metabolite of sibutramine, didesmethylsibutramine contributes to the pharmacological effects of the parent drug. Sibutramine and its metabolites, including didesmethylsibutramine, function primarily by inhibiting the reuptake of neurotransmitters such as serotonin, norepinephrine, and dopamine. This action increases the levels of these neurotransmitters in the synaptic cleft, leading to enhanced satiety and reduced appetite.

Clinical Significance

Sibutramine was withdrawn from the market in many countries due to concerns about its cardiovascular safety profile. The presence of active metabolites like didesmethylsibutramine was considered in the overall assessment of the drug's safety and efficacy. Understanding the role of metabolites is crucial in evaluating the pharmacokinetics and potential side effects of pharmaceutical agents.

Related Compounds

Didesmethylsibutramine is related to other metabolites of sibutramine, such as monodesmethylsibutramine. These metabolites are part of the metabolic pathway that influences the drug's activity and duration of action in the body.

Related Pages

@@ Line 1: / Line 1: @@
-'''Didesmethylsibutramine''' is a [[pharmaceutical drug]] that is primarily used as an [[appetite suppressant]]. It is a metabolite of [[sibutramine]], a drug that was previously used for the treatment of [[obesity]] but was withdrawn from the market due to associated health risks.
+{{DISPLAYTITLE:Didesmethylsibutramine}}
-==Pharmacology==
+== Didesmethylsibutramine ==
-Didesmethylsibutramine acts by inhibiting the reuptake of [[neurotransmitters]] such as [[serotonin]], [[norepinephrine]], and to a lesser extent, [[dopamine]]. This results in increased levels of these neurotransmitters in the synaptic cleft, which in turn suppresses appetite.
-==Clinical Use==
+[[File:Didesmethylsibutramine BTS-54524.svg|thumb|right|Chemical structure of Didesmethylsibutramine]]
-Didesmethylsibutramine was never approved for use as a standalone drug. However, it is a primary metabolite of sibutramine, which was used for the treatment of obesity. Sibutramine was withdrawn from the market in many countries due to an increased risk of cardiovascular events and strokes.
-==Side Effects==
+'''Didesmethylsibutramine''' is a chemical compound that is a metabolite of the drug [[sibutramine]]. Sibutramine is a medication that was used as an [[appetite suppressant]] for the treatment of [[obesity]]. Didesmethylsibutramine is formed in the body through the metabolic process of [[N-demethylation]], which removes methyl groups from the parent compound.
-The side effects of didesmethylsibutramine are similar to those of sibutramine. These can include [[dry mouth]], [[insomnia]], [[constipation]], and increased heart rate. More serious side effects can include high blood pressure and an increased risk of cardiovascular events.
-==Regulation==
+== Chemical Properties ==
-Due to its association with sibutramine, didesmethylsibutramine is also regulated in many countries. It is often included in the list of substances that are tested for in anti-doping screenings.
+Didesmethylsibutramine is classified as a [[phenethylamine]] and an [[amphetamine]] derivative. Its chemical structure is characterized by the presence of a phenyl ring and an amine group, which are common features in compounds that affect the [[central nervous system]].
+== Pharmacology ==
+As a metabolite of sibutramine, didesmethylsibutramine contributes to the pharmacological effects of the parent drug. Sibutramine and its metabolites, including didesmethylsibutramine, function primarily by inhibiting the reuptake of [[neurotransmitters]] such as [[serotonin]], [[norepinephrine]], and [[dopamine]]. This action increases the levels of these neurotransmitters in the synaptic cleft, leading to enhanced satiety and reduced appetite.
+== Clinical Significance ==
+Sibutramine was withdrawn from the market in many countries due to concerns about its cardiovascular safety profile. The presence of active metabolites like didesmethylsibutramine was considered in the overall assessment of the drug's safety and efficacy. Understanding the role of metabolites is crucial in evaluating the pharmacokinetics and potential side effects of pharmaceutical agents.
+== Related Compounds ==
+Didesmethylsibutramine is related to other metabolites of sibutramine, such as [[monodesmethylsibutramine]]. These metabolites are part of the metabolic pathway that influences the drug's activity and duration of action in the body.
+== Related Pages ==
-==See Also==
 * [[Sibutramine]]
 * [[Appetite suppressant]]
-* [[Obesity]]
+* [[Phenethylamine]]
+* [[Neurotransmitter]]
-{{Pharma-stub}}
-[[Category:Pharmaceutical drugs]]
+[[Category:Phenethylamines]]
+[[Category:Metabolites]]
 [[Category:Appetite suppressants]]
-[[Category:Obesity]]